Lion Corporation
10.20
EUR
0.00
(0.00%)
ISIN
JP3965400009
Return %
Stock
S&P 500
1Y
17.24
14.20
3Y
15.91
81.12
5Y
-27.66
68.34
Capital Structure
JPY
•
in mil. unless spec.Working Capital
JPY
•
in mil. unless spec.Growth Rates
JPY
•
in mil. unless spec.Quarterly Revenue
JPY
•
in mil. unless spec.Quarterly Earnings Per Share
JPY
•
in mil. unless spec.Quarterly Dividends Per Share
JPY
•
in mil. unless spec.Company Description
- CEO
- Masayuki Takemori
- Full Time Employees
- 8,346
- Sector
- Consumer non-durables
- Industry
- Household/Personal care
- Address
- 1-3-28, Kuramae Tokyo TY Japan 111-8644
- IPO Date
- May 16, 1949
- Website
- lion.co.jp
- Similar Companies
- Business
- Lion Corporation manufactures and sells a broad range of household, personal care, and industrial products primarily in Japan and select overseas markets including Asia. The company operates through segments encompassing general consumer goods such as toothpastes including brands like Clinica, toothbrushes, soaps, detergents, hair care and skin care products, pharmaceuticals, pet food, and over-the-counter medications; industrial goods including kitchen cleansers and chemical materials; and overseas operations focused on consumer goods and chemicals. Founded in 1891 and headquartered at 1-3-28 Kuramae, Taito-ku, Tokyo, Japan, Lion Corporation employs approximately 7,654 people on a consolidated basis and maintains 12 offices and plants along with 9 affiliates across 11 sites. The company targets everyday consumers, households, pet owners, and industrial clients through agent stores, retail channels, e-commerce, and exports to overseas affiliates, with a strong emphasis on oral care where it leads as Japan's top maker of toothpastes and toothbrushes. Lion also engages in equipment design, construction, maintenance, product transportation, real estate, agency, and welfare businesses to support its core operations. In recent developments, Lion Corporation signed a partnership agreement with Japan Activation Capital, Inc. in October 2024, under which JAC acquired common shares to support sustainable growth, profitability improvements, and overseas expansion as part of the company's Vision2030 1st STAGE medium-term management plan. In April 2025, Lion agreed to acquire the remaining 64% stake in its equity-method affiliate Merap Lion Holding Corporation in Vietnam, converting it into a wholly owned subsidiary by July 2025 to enhance synergies in pharmaceuticals, medical devices, oral healthcare, distribution networks, and product development. These moves align with Lion's strategic focus on portfolio management, overseas growth, and revitalizing its profit base ahead of the next medium-term plan.